The α7 Nicotinic Acetylcholine Receptor: A Promising Target for the Treatment of Fibrotic Skin Disorders. [electronic resource]
Producer: 20210401Description: 2371-2379 p. digitalISSN:- 1523-1747
- Adenoviridae -- genetics
- Animals
- Bleomycin -- toxicity
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Cells, Cultured
- Collagen -- metabolism
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Fibroblasts -- drug effects
- Fibrosis
- Genetic Vectors -- administration & dosage
- Humans
- Male
- Mice
- Primary Cell Culture
- Quinuclidines -- pharmacology
- Receptor, Transforming Growth Factor-beta Type I -- genetics
- Scleroderma, Systemic -- chemically induced
- Skin -- cytology
- alpha7 Nicotinic Acetylcholine Receptor -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.